Geriatric Healthcare Specialist Jonesboro AR

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment.

Terry Dean Weaver, MD
(808) 523-8461
528 E Washington Ave
Jonesboro, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: In Univ Sch Of Med, Indianapolis In 46202
Graduation Year: 1995

Data Provided by:
James Mark Robinette
(870) 932-2423
801 Osler Dr Ste A
Jonesboro, AR
Specialty
Family Practice, Geriatric Medicine

Data Provided by:
Nidal Younis Rahal, MD
(870) 295-5225
530 Atkins Blvd
Marianna, AR
Specialties
Geriatrics, Geriatric Medicine-Family Practice
Gender
Male
Education
Medical School: Univ Of Damascus, Fac Of Med, Damascus, Syria
Graduation Year: 1997

Data Provided by:
Zulekha Hamid, MD
Little Rock, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Dow Med Coll, Univ Of Karachi, Karachi, Pakistan
Graduation Year: 1996

Data Provided by:
Kathryn I Reeder, MD
(501) 327-5440
32 Military Ridge Rd
Conway, AR
Specialties
Internal Medicine, Geriatrics
Gender
Male
Education
Medical School: Univ Of Ar Coll Of Med, Little Rock Ar 7
Graduation Year: 1946

Data Provided by:
Thomas Mulligan
(870) 336-5080
303 E Matthews Ave Ste 202
Jonesboro, AR
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Delbra Ruth Caradine, MD
(501) 374-5950
PO Box 1113
Little Rock, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Univ Of Ar Coll Of Med, Little Rock Ar 72205
Graduation Year: 1983

Data Provided by:
Noel Melendres Medel, MD
(501) 279-7077
403 S Poplar St Ste E
Searcy, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Santo Tomas, Fac Of Med And Surg, Manila, Philippines
Graduation Year: 1981

Data Provided by:
Bushra Shah
(501) 552-4777
1 Saint Vincent Cir
Little Rock, AR
Specialty
Family Practice, Geriatric Medicine

Data Provided by:
Katherine Lynn Mitchell, MD
10000 N Rodney Parham Rd
Little Rock, AR
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Univ Of Az Coll Of Med, Tucson Az 85724
Graduation Year: 1998

Data Provided by:
Data Provided by:

Food for Thought

Provided by: 

By Kris Kucera

Rarely does an extended family get a free pass from Alzheimer’s disease or diabetes mellitus. On the surface, these two afflictions appear totally unrelated —Alzheimer’s (AD), Mother Nature’s cruel version of identity theft; and diabetes, the glucose-metabolism disorder that affects both young and old alike. However, new research indicates that the two diseases behave in a similar manner.

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment. This, they say, suggests that a form of diabetes, tentatively dubbed type 3, leads to AD.

Type 1 diabetes results from a severe or complete lack of insulin, a hormone made in the pancreas that controls blood sugar. Type 2, dubbed adult onset diabetes (although these days it occurs in teenagers and even younger kids), also stems from a dearth of insulin, or insulin resistance —the existing insulin molecules cannot deliver glucose through the cells’ membranes. Surprisingly, the researchers found a new form of insulin, produced in the brain, and they believe that, over time, decreasing levels of this “brain insulin” and other insulin-related proteins ultimately precipitate AD. While levels of brain insulin have no known affect on a body’s overall blood sugar, scientists have long recognized that diabetes patients are more likely to develop AD than those without the disease.

Skeptics of the Brown team’s findings argue that our brains produce so little insulin in the first place, reduced levels of the hormone can’t possibly play a significant role in AD. Regardless, the new data show that AD may be a neuroendocrine disorder, thus increasing the possibility for more effective treatments. And that gives hope to all of us who may one day be touched, directly or indirectly, by the merciless hand of AD.

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...

Click here to read more from Natural Solutions